Accumulation of CD103+ CD8+ T cells in a cutaneous melanoma micrometastasis

Katharina Hochheiser1,2, Han Xian Aw Yeang1,3, Teagan Wagner2,4

  • 1Peter MacCallum Cancer Centre Melbourne VIC Australia.

Abstract

Insights

Tissue-resident memory T (TRM) cells, specifically CD103+ CD8+ TRM cells, are crucial for controlling occult melanoma micrometastases. These cells surround and likely eliminate early-stage cancer cells, highlighting their role in immune surveillance.

Area of Science:

  • Immunology
  • Dermatology
  • Oncology

Background:

  • The immune system can prevent cancer progression by controlling small, undetectable metastases.
  • Cutaneous melanoma offers a model to study the immune environment of these early-stage lesions.

Observation:

  • A patient with melanoma presented with both an overt and an occult in-transit metastasis (ITM).
  • Multiplex immunofluorescence microscopy was used to analyze the immune composition of both lesions.

Findings:

  • The overt ITM showed T cells at the tumor margin, excluding the center.
  • The occult micrometastasis had few melanoma cells scattered within a dense T cell infiltrate.
  • A significant population of CD103+ CD8+ T cells, resembling tissue-resident memory T (TRM) cells, were found in the occult lesion, closely interacting with melanoma cells.

Implications:

  • CD103+ CD8+ TRM cells are key mediators of cancer immune surveillance.
  • These TRM cells play a critical role in controlling clinically occult micrometastases in humans.